| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/11/2023 | Sigilon Therapeutics, Inc. | | Disposition | Stock Option (Right to Buy) | 4.3k | $7.51 | $32.1k | | 08/11/2023 |
| 08/11/2023 | Sigilon Therapeutics, Inc. | | Disposition | Stock Option (Right to Buy) | 683 | $5.00 | $3.4k | | 08/11/2023 |
| 08/11/2023 | Sigilon Therapeutics, Inc. | | Disposition | Stock Option (Right to Buy) | 683 | $6.64 | $4.5k | | 08/11/2023 |
| 05/17/2023 | Paragon 28, Inc. | FNA | Grant | Common Stock | 8.4k | $0.00 | $0 | | 05/17/2023 |
| 05/26/2022 | Sigilon Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 8.9k | $0.76 | $6.8k | | 05/26/2022 |
| 05/18/2022 | Paragon 28, Inc. | FNA | Grant | Common Stock | 8.9k | $0.00 | $0 | | 05/18/2022 |
| 05/03/2022 | BAXTER INTERNATIONAL INC | BAX | Grant | Common Stock, $1 par value | 2.7k | $0.00 | $0 | | 05/03/2022 |
| 10/14/2021 | Paragon 28, Inc. | FNA | Grant | Common Stock | 7k | $0.00 | $0 | | 10/14/2021 |
| 06/24/2021 | Sigilon Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 8.9k | $9.97 | $88.6k | | 06/24/2021 |
| 05/04/2021 | BAXTER INTERNATIONAL INC | BAX | Grant | Common Stock, $1 par value | 2.2k | $0.00 | $0 | | 05/04/2021 |
| 12/03/2020 | Sigilon Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 8.9k | $18.00 | $160k | | 12/03/2020 |
| 05/05/2020 | BAXTER INTERNATIONAL INC | BAX | Grant | Common Stock, $1 par value | 2.2k | $0.00 | $0 | | 05/05/2020 |
| 05/07/2019 | BAXTER INTERNATIONAL INC | BAX | Grant | Common Stock, $1 par value | 2.4k | $0.00 | $0 | | 05/07/2019 |
| 06/29/2018 | REVA Medical, Inc. | RVA.AX | Purchase | Common Stock | 16.4k | $1.53 | $25k | | 06/29/2018 |
| 05/16/2018 | REVA Medical, Inc. | RVA.AX | Grant | Stock Option (right to buy) | 6.9k | $1.96 | $13.6k | | 05/16/2018 |
| 05/16/2018 | REVA Medical, Inc. | RVA.AX | Grant | Stock Option (right to buy) | 80k | $1.96 | $156.8k | | 05/16/2018 |
| 05/08/2018 | BAXTER INTERNATIONAL INC | BAX | Grant | Common Stock, $1 par value | 2.7k | $69.45 | $185k | | 05/08/2018 |